![](https://static.wixstatic.com/media/7fb8ed_942e2538fa7744aa9b8cf5338ef02f75~mv2.jpg/v1/fill/w_147,h_72,al_c,q_80,usm_0.66_1.00_0.01,blur_2,enc_auto/7fb8ed_942e2538fa7744aa9b8cf5338ef02f75~mv2.jpg)
ChromaDex share price reached about $3.67 on January 6, moments before the news of the Elysium lawsuit was announced in an SEC filing.
Then share price dropped rapidly, stabilizing at around $2.80 in mid-February.
Between mid-February and mid-April, short interest rose from about 1.2M shares to 1.8M shares -- a 50% increase. This correlated with a decline in share price from about $2.80 to about $2.30, roughly 18% decrease.
TL;DR: It appears that litigation drove share prices down in January, but since mid-February the shorts have been responsible for the additional price drops.